6 Analysts Assess Amylyx Pharma: What You Need To Know
6 Analysts Assess Amylyx Pharma: What You Need To Know
6位分析師評估Amylyx Pharma：你需要知道的
Across the recent three months, 6 analysts have shared their insights on Amylyx Pharma (NASDAQ:AMLX), expressing a variety of opinions spanning from bullish to bearish.
在過去的三個月中，6位分析師將他們對Amylyx Pharma（納斯達克：AMLX）的見解分享出來，表達了從看好到看淡的各種觀點。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表提供了他們最近的評級快照，展示了情緒在過去30天中的演變情況，並將其與之前的月份進行比較。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $6.33, a high estimate of $8.00, and a low estimate of $3.00. A decline of 1.09% from the prior average price target is evident in the current average.
分析師評估的12個月價格目標揭示了更多的信息，其中包括平均目標價爲6.33美元，最高預估價爲8美元，最低預估價爲3美元。當前的平均價格目標較前一個平均價格目標下降了1.09%。
Interpreting Analyst Ratings: A Closer Look
解讀分析師評級：更深入的了解
The standing of Amylyx...
通過對最...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。